Roslin Technologies

Roslin Technologies

Private
Edinburgh, ScotlandHealthcare & Life Scienceshttps://www.roslintech.com

Last Round

Early Funding

Jan 30, 2025

Total Funding Raised

$26.63M

Company Overview

Roslin Technologies is a Scottish biotechnology company that develops and commercializes animal cell lines for the cultivated meat and animal health sectors. A spin-out from the University of Edinburgh's Roslin Institute, where Dolly the sheep was cloned, the company leverages cutting-edge stem cell technology. Its primary focus is providing high-quality pluripotent and induced pluripotent stem (iPS) cells for livestock and companion animals to the global cultivated meat industry, enabling producers to create scalable, safe, and affordable meat alternatives. The company's product portfolio includes cell lines for beef, pork, and lamb, along with the necessary growth media and protocols to help customers accelerate their market entry. In addition to cultivated meat, Roslin Technologies is also involved in developing cell therapy solutions for companion animals and breeding programs for the insect protein sector. The company is venture-backed and was founded in 2017.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

animal stem cell linescultivated meatpluripotent stem cellslab-grown meatcell-based meatiPSCsinduced pluripotent stem cellscellular agricultureimmortal cell linescell line suppliergrowth mediabioprocess protocolsB2B licensinggenomic servicesavian biopharming

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Roslin Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Roslin Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 30, 2025
Series A ExtensionJun 16, 2023
Series ANov 3, 2022
GrantNov 4, 2021
SeedApr 12, 2017

Key People

Founding team and executive leadership

Ernst van Orsouw

Chief Executive Officer

Executive Team

Jacqui Matthews BVMS PhD FRSB FRCVS RCVS Specialist

Chief Technology Officer

Executive Team

Roslin Technologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2025

    Co-presenting on process innovations at the NAPIC Inaugural Conference 2025.

Roslin Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Roslin Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Roslin Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh, Scotland
Employee Range35
Year Founded2017
Last FundingJan 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.